TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer Advanced Oncotherapy or the underlying issuer plc of existing shares to which voting rights are attached: (ii) ----------------------------- --------------------- 2 Reason for the notification (please tick the appropriate box or boxes): --------------------------------------------------- An acquisition or disposal of voting rights X ----------------------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ----------------------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ----------------------------------------------- An event changing the breakdown of voting rights ----------------------------------------------- Other (please specify): --------------------------------------------- 3. Full name of person(s) AB Segulah subject to the notification obligation: (iii) ---------------------------------- -------------------- 4. Full name of shareholder(s) HSBC Global Custody (if different from 3.): Nominee (UK) (iv) ---------------------------------- -------------------- 5. Date of the transaction 20 March 2017 and date on which the threshold is crossed or reached: (v) ---------------------------------- -------------------- 6. Date on which issuer 20 March 2017 notified: ---------------------------------- -------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 5% ---------------------------------- -------------------- 8. Notified details: ---------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------- Class/type Situation Resulting situation after of previous the triggering transaction shares to the triggering transaction if possible using the ISIN CODE --------------- ---------------------- ----------------------------------------------------- Number Number Number Number of % of voting of of of voting rights (x) Shares Voting shares rights Rights --------------- ---------- ---------- ---------- --------------------- ------------------ Direct Direct Indirect Direct Indirect (xi) (xii) --------------- ---------- ---------- ---------- ---------- --------- ------- --------- Ordinary Shares GBP 0.25 GB00BD6SX109 3,505,451 3,505,451 3,680,451 3,680,451 5.06%
Advanced Oncotherapy expected to disrupt the market says Hardman & Co (LON:AVO)
Hardman and Co’s Dr Martin Hall discusses Advanced Oncotherapy plc in this exclusive interview with DirectorsTalk.